[FEATURED] Virpax inks ‘patch-in-a-can’ deal for pain management
July 3, 2018
Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products.
NASDAQ: VRPX
Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
Phone 610.727.4597
Email info@virpaxpharma.com
NASDAQ: VRPX
Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
Phone 610.727.4597
Email info@virpaxpharma.com
© Virpax® Pharmaceuticals. All Rights Reserved.
© Virpax® Pharmaceuticals. All Rights Reserved.
